In just a few short years, the rapid proliferation of AI has turned what was once the stuff of dystopian sci-fi into a reality. LeBlanc argues humanoid soldiers are a natural extension of existing ...
March 5, 2026, XGSynBot a pioneer in embodied AI, hosted its 2026 product dual-city launch event themed "More Than One Answer" in both Silicon Valley and Beijing. The company officially debuted the Z1 ...
AMD said its processors can be deployed in a range of industries, including industrial PCs for the intelligent factory and autonomous robots.
The Mexican city of Guadalupe, which will host portions of the 2026 World Cup, recently showed off four new robot dogs that will help provide security during matches at BBVA Stadium. The “K9-X” unit ...
A full-size humanoid robot just ran faster than most people will ever sprint. Chinese robotics firm MirrorMe Technology has unveiled Bolt, a humanoid robot that reached a top speed of 22 miles per ...
Humanoid robots are no longer hiding in research labs somewhere. These days, they are stepping into public spaces, and they are starting to look alarmingly human. A Shanghai startup has now taken that ...
For all its success across a wide range of cancer types, Merck’s PD-1 superstar Keytruda has never been able to crack the code for one of the toughest-to-treat indications in oncology—ovarian cancer.
Last year, 21 humanoid robots squared up against each other in the World Humanoid Robot Games’ half marathon race in Beijing in an unintentionally hilarious debauchery of broken limbs, face plants — ...
A hotly-anticipated line of humanoid robots is giving a whole new meaning to the concept of "stranger danger". The 1X NEO robot is set to become one of the first mass-marketed humanoid robots ...
Tesla CEO Elon Musk acknowledged the possibility that Optimus could overshadow the legacy of the brand’s electric vehicles. Tesla lost EV sales leadership to BYD in 2025 amid regulatory challenges.
HONG KONG, Jan. 13, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium ...
A recent real-world study provides new evidence addressing this challenge. In this retrospective analysis, patients with PD-L1-low (CPS < 5) advanced G/GEJ cancer received first-line therapy with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results